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During development, many neurons display calci-
um-dependent migration, but the role of this mes-
senger in regulating gene expression leading to
this event has not yet been elucidated. Among the
decoders of calcium signals is calcineurin, a Ca2/
calmodulin serine/threonine phosphatase that has
been involved in both short-term and long-term
cellular changes. By using immortalized GnRH-se-
creting neurons, we now show that, in vitro, Ca2-
dependent gene expression, proceeding via cal-
cineurin and the transcription factor nuclear factor
of activated T cells, is a key player controlling the
chemomigratory potential of developing GnRH-se-
creting neurons. Furthermore, our data highlight
the switch nature of this phosphatase, whose ac-
tivation or inactivation guides cells to proceed
from one genetic program to the next. (Molecular
Endocrinology 22: 729–736, 2008)
CALCINEURIN IS A Ca
2/calmodulin-dependent
phosphatase that acts downstream of Ca2 mo-
bilization to induce short-term and long-term changes
(1). Calcineurin is highly abundant in the brain, and its
role in short-term neuronal events, i.e. regulation of the
phosphorylation status of key proteins, has been well
investigated (2). Calcineurin-induced gene expression
changes have been shown to be crucial in a number of
models, including T lymphocytes, heart, muscle, ker-
atinocytes, and more recently, -pancreatic acinar
cells (3), but in the brain this aspect has so far been
given less consideration. Calcineurin and its down-
stream transcription factor nuclear factor of activated
T cells (NFAT) have been linked to changes in gene
expression in hippocampal neurons (4) and cerebellar
granule cells (5) in response to electrical activity and to
neurotrophic factors (6, 7). In cerebellar granule cells,
for example, it induces significant changes in gene
expression patterns in proteins involved in Ca2 ho-
meostasis and in glutamatergic transmission (8, 9). It
has also been shown that this pathway is required for
the stimulation of axonal outgrowth by neurotrophins
and netrins (7). Furthermore, an isoform of calcineurin
has been linked to schizophrenia both in human as-
sociation studies (10) and in mouse experiments (11),
and NFAT dysregulation has been postulated to be
linked to some of the neurological features of Down’s
syndrome (12). Two recent microarray experiments
have also suggested that calcineurin might be key in
the switching between gene expression programs in
cerebellar granule neurons (13, 14), although no func-
tional data were reported.
It is well established that calcium signals are crucial
during migration (15), but based on the microarray
observations described above, we felt it necessary to
establish whether the Ca2/calcineurin/NFAT pathway
might play a role upstream of this behavior, by either
priming or inhibiting the migratory potential of neu-
rons. To elucidate this, we employed an immortalized
neuroendocrine cell line, GN11, that has been well
characterized as a model for migratory neurons (16).
GnRH-secreting neurons, like olfactory neurons, orig-
inate in the olfactory placode (embryo stage E11.5 in
mouse), which will later develop into the olfactory ep-
ithelium. During development, GnRH neurons migrate
into the forebrain to reach their final septohypotha-
lamic localization. GN11 cells were first obtained from
the olfactory bulb and have been found to retain the
phenotypic characteristics of immature GnRH neurons
(16), thereby showing high migratory activity in vitro.
As a comparison, we also employed GT1-7 cells,
which were first obtained from the hypothalamus and
retain the characteristics of nonmigrating mature
GnRH-neurons.
We now show that in migratory GN11 neurons, un-
like in GT1-7 neurons, basal cytosolic calcium is suf-
ficient to activate calcineurin, and in turn this activates
the transcription factor NFAT. Chronic inhibition of
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either calcineurin or NFAT decreases significantly the
ability of cells to undergo chemomigration.
RESULTS AND DISCUSSION
To establish whether calcineurin plays a role in the
migration of GN11 cells, we incubated cells with the
specific inhibitors FK506 (100 nM) or CsA (1 M) for
48 h and then performed microchemotaxis (chemomi-
gration) assays using the Boyden’s chamber. Such an
incubation resulted in a significant reduction in migra-
tion when 1% fetal calf serum (FCS) was used as
chemoattractant (16) (Fig. 1A). Cells that were not
preincubated with inhibitors but that were acutely ex-
posed to the inhibitors only during the migration assay
(3 h) did not display any difference compared with
control (Fig. 1A). Our data therefore suggest that cal-
cineurin does not play a direct role in migration itself,
but its chronic inhibition disrupts the capacity of cells
to undergo this process. Furthermore, when a time
course of preincubation was performed with FK506, a
correlation between time of exposure and migration
emerged (Fig. 1B). Rapamycin, a structural analog of
FK506 devoid of activity on calcineurin, also had a
significant effect on migration, although the extent was
significantly inferior to that displayed by FK506 or
cyclosporin A. Although we did not pursue this further,
rapamycin has as its main target the protein mamma-
lian target of rapamycin (mTOR), and it is not unlikely
that this, or other pathways, might also control
migration.
The change in migratory behavior of cells treated
with FK506 or CsA could not be attributed to gross
morphological changes because phalloidin staining
did not reveal qualitative or quantitative differences
between control cells and those treated with cal-
cineurin inhibitors (Fig. 2). Furthermore, cell viability
and proliferation were not affected by 48 h treatment
with these compounds as measured by the MTT assay
(control, 100  6%; 100 nM FK506, 90  4%; 1 M
CsA, 91  2%). On the other hand, although rapamy-
cin did not have an effect on viability and proliferation
(91 2%), it did show an effect on GN11 morphology,
namely cells appeared enlarged and flattened and had
taken on a more rounded shape. Last, it has been
previously reported that GN11 cells might not be a
homogeneous population (17) and that only 80–90%
of cells are GnRH positive. We therefore analyzed
whether FK506 might select only the positive or neg-
ative population for cell growth. This was not the case,
and in our population, all control and FK506-treated
cells were GnRH positive.
In the chemomigration experiments described
above (Fig. 1), cells were grown in the presence or
absence of calcineurin inhibitors, but no stimulation
was provided. Because the canonical activator of cal-
cineurin is Ca2, we decided to investigate basal cal-
cium signaling in these cells. Under basal culture con-
ditions, GN11 cells displayed an oscillatory Ca2
pattern in 20% of cells (n  228). This behavior was
observed in the presence (20.2%, n 163) or absence
(20.0%, n  65) of serum in the medium (Fig. 3).
Oscillations were inhibited in 50% of cells tested (n 
6) by acute application of the nonspecific Ca2 antag-
onist 2-aminoethoxydiphenyl borate (2-APB) (100 M,
Fig. 3) and observed in only 2.6% of cells (nine of 343)
after 40 h of incubation with this membrane-perme-
Fig. 1. Chronic, But Not Acute, Inhibition of Calcineurin Inhibits Chemomigration
A, Effect of acute (white bars) or chronic (black bars) treatment of GN11 cells with FK506 (100 nM; n 54 from nine independent
experiments), CsA (1 M; n 18 from three independent experiments) or rapamycin (1 M; n 24 from four independent
experiments) on migration. Cells were pretreated for 48 h and allowed to migrate for 3 h. Compounds were added either in the
first period (48 h) or in the second (3 h). B, Time course of preincubation with FK506 (100 nM) on migration (n 18 from three
separate experiments). Experimental protocol was identical to that outlined in A, but preincubation time was varied as depicted
in the figure. Values are mean  SEM. *, P  0.01; #, P  0.05 compared with respective controls using one-way ANOVA followed
by Tukey’s test.
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able calcium modulator. When we compared GN11
cells to GT1-7 cells, the mature equivalent of GN11
cells, the most striking difference was represented by
basal calcium, which was considerably higher in the
migration-competent cell line (99  16 nM, n 19, vs.
63  6 nM, n 25, respectively).
To confirm that calcineurin is active in our condi-
tions, we performed a luciferase reporter assay with a
construct driven by NFAT in GN11 cells and in GT1-7
cells. Indeed, NFAT-driven expression was present in
GN11 cells under basal nonstimulated conditions and
was abolished by incubation with FK506 or CsA (Fig.
4A). In the sister cell line GT1-7, calcineurin activity,
defined as luciferase activity inhibited by either FK506
or CsA, was not constitutively present (Fig. 4A). Addi-
tional evidence of the lack of calcineurin activity can
be implied by the absence of an effect of dominant-
negative calcineurin and NFAT in luciferase experi-
ments (Fig. 5A). Surprisingly, NFATc4, the isoform bet-
ter characterized in brain, was present in GN11 cells
but absent in GT1-7 cells (Fig. 4B). Our data suggest
that the calcineurin signaling pathway is active in mi-
gration-competent neurons and undergoes changes
upon completion of migration. We and others (4, 5)
have previously shown that activation of L-type Ca2
channels regulated calcineurin activity. To investigate
whether this was true also in our system, we incubated
cells for 48 h with nifedipine (1 M) and assayed for
migration. Inhibition of L-type calcium channels was
unable to influence migration of GN11 cells compared
with control (control, 100  16%; nifedipine, 114 
14%). The inability of nifedipine to influence migration
was substantiated by the absence of a calcium re-
sponse in high potassium (44 mM; data not shown) and
by previous reports that suggest that these cells (un-
like GT1-7) are devoid of voltage-operated Ca2 chan-
nels (17). We also attempted to grow cells in the pres-
ence of thapsigargin, but this treatment was highly
cytotoxic and could not be used.
To establish whether a correlation existed between
Ca2 oscillations, activation of the calcineurin-NFAT
pathway, and the migratory behavior of GN11 cells, we
analyzed the effects of 2-ABP, the only compound that
affected basal calcium signaling (i.e. blocking oscilla-
tions) on GN11 cells transfected with the luciferase
reporter construct and in chemomigration assays.
2-APB was unable to block NFAT-driven luciferase
expression (141  15% of control; n 11), suggesting
that the elevated resting Ca2 in these migration-com-
petent cells (previous paragraph) might be sufficient to
drive the activation of the calcineurin-NFAT pathway.
In support of this, incubation of 2-APB alone did not
reduce chemomigration of GN11 cells (Fig. 4C). Sur-
prisingly, though, incubation with 2-APB was able to
partially rescue the block in migratory potential in-
duced by FK506 (Fig. 4C). Experiments directed at
clarifying this showed that incubation with 2-APB did
not reduce significantly basal calcium levels (basal cell
calcium after 40 h incubation was 89 13% of control
cells), suggesting that calcium on its own could not
provide an explanation for this paradoxical effect of
2-APB. The rescue observed might in principle be
explained by the activation of a parallel pathway by
2-APB treatment. Indeed, preliminary experiments
from our lab (Genazzani, A. A., and S. Tacchi, unpub-
lished) suggest that this might occur. In brief, in control
GN11 cells, preincubation for 48 h with wortmannin
elicits no effect, whereas in cells treated with FK506
Fig. 2. Inhibition of Calcineurin Does Not Change Morphology of GN11 Cells
Cells were treated with FK506 (100 nM), CsA (1 M), or rapamycin (Rap) (1 M) for 48 h and stained with phalloidin-fluorescein
isothiocyanate. Figures are representative of two separate experiments. No significant toxicity was elicited by any of the three
pharmacological agents (see text for details).
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plus 2-APB, preincubation with wortmannin yields a
significant reduction in migratory potential. These data
suggest that 2-APB pretreatment unmasks a new
pathway that can support migration in the absence of
calcineurin activity. Whether this unmasking of a par-
allel, redundant pathway is correlated with the abol-
ishment of calcium oscillations remains to be
established.
Although our data demonstrate the involvement of
calcineurin and the endogenous activation of the
NFAT pathway, formal proof that the calcineurin/NFAT
pathway is implicated in the migratory behavior is
required. To establish this, we transfected cells with
the truncated form either of calcineurin A (CaNA) or
of NFAT (NFAT), both of which are constitutively
active (18). Indeed, control experiments established
that both plasmids were able to considerably increase
NFAT-driven luciferase expression (Fig. 5A). To un-
mask the effect of an increase of calcineurin activity
over background, fewer cells were seeded in the
Boyden’s chamber and exposed to a reduced chemo-
tactic stimulus (0.1% FCS). In these conditions, GN11
cells transfected with either of the two plasmids sig-
Fig. 3. Characterization of Basal Nonstimulated Ca2 in
GN11 Cells
Representative traces of the oscillatory Ca2 pattern in
GN11 cells: spontaneous oscillations observed in presence
(A) or absence (B) of serum in the medium and effect of
2-APB 100 M (C) (three of six displayed an instant block
of oscillations). In cells treated for 40 h with 2-APB, the
effect of the blocker was complete (only nine of 343
showed a modest spontaneous calcium activity).
Fig. 4. Characterization of the Ca2/Calcineurin/NFAT Path-
way under Basal Conditions in GN11 Cells
A, NFAT-driven luciferase activity in GN11 or GT1-7 cells in
the presence or absence of FK506 (100 nM) or CsA (1 M) for
48 h. Note that in GT1-7 cells, activity appears to represent
background noise, because it cannot be inhibited by cal-
cineurin antagonists. Values are mean  SEM of five to 15
replicates in one to three separate experiments. B, Western
blot of NFATc4 in two separate preparations of GN11 and
GT1-7 cells; 30 g protein was loaded in each well. C, Effect
of 2-APB on migration. Values are SEM of 12–18 replicates
from two to three experiments. *, P  0.01; #, P  0.05
compared with respective controls using one-way ANOVA,
followed by Tukey’s test.
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nificantly increased their migratory response (130 
5% for CaNA and 131  5% for NFAT of control
migration; P 0.01). To further strengthen this finding,
a stable cell line overexpressing NFAT was gener-
ated. Indeed, these overexpressing cells displayed a
significantly higher migration behavior compared with
the respective control (178  4%).
If our hypothesis is correct, and calcineurin indeed
plays a permissive role toward migration by regulating
gene expression, one would expect that overexpres-
sion of dominant-negatives or negative regulators
should decrease migration. Cells were therefore co-
transfected with vectors coding for CaIN, an inhibitor
of calcineurin (19), or with a dominant-negative NFAT
(amino acids 1–317, lacking the DNA-binding domain;
Fig. 5A for inhibitory activity on luciferase) and co-
transfected with a green fluorescent protein (GFP)
marker plasmid. After 72 h of culture, cells were sorted
by fluorescence flow cytometry and GFP or GFP
cells were allowed to migrate in the Boyden’s chamber
vs. 0.1% serum, as described above. Cells expressing
either CaIN or dominant-negative NFAT (GFP) dis-
played a markedly reduced chemomigratory response
to serum with respect to untransfected cells (GFP,
Fig. 5B), thereby confirming the involvement of both
the phosphatase and its downstream transcription
factor in migration of GN11 cells in vitro.
It would be extremely important in the future to
understand which proteins are controlled by cal-
cineurin at a transcriptional level to allow the permis-
sive role on migration to occur. We have previously
shown that brain-derived neurotrophic factor (BDNF)
is controlled by this phosphatase in cerebellar granule
cells (20). Furthermore, it has been shown that BDNF
can control calcineurin activity (6) and that it has a
neurotrophic effect on embryonic GnRH-secreting
neurons (21). These data, taken together, prompted us
to investigate whether a relationship exists between
calcineurin-dependent migration and BDNF. Treat-
ment of cells for 48 h with BDNF (30 ng/ml) did not
alter migratory behavior of control GN11 (control,
100  2%; BDNF, 99  2%) or FK506-treated cells
(FK506, 61  3%; FK506 plus BDNF, 52  3%). Fur-
thermore, unlike in cerebellar granule cells, calcineurin
inhibition did not alter mRNA levels for BDNF, as an-
alyzed by PCR (data not shown). It would therefore
appear that BDNF does not mediate migration of these
cells, nor is it controlled at a transcriptional level by
calcineurin.
In conclusion, in the present manuscript, we show
that the chronic activation of the Ca2/calcineurin/
NFAT pathway primes GnRH neurons to undergo mi-
gration. This statement is supported by pharmacolog-
ical and molecular evidence. In brief, inhibition of
calcineurin by FK506, CsA, CaIN, and a dominant-
negative NFAT reduces the migratory potential of neu-
rons, whereas molecular potentiation of the pathway
(constitutively active CaN or NFAT) augments migra-
tion. Inhibition of this pathway during migration is un-
able to exert any effect, confirming that the mecha-
nism of action is at the transcriptional/preparatory
level in neurons. Conclusive proof that calcineurin reg-
ulates migration at a transcriptional level and whether
this is a direct effect or mediated by synthesis of other
proteins would come from the use of transcription (e.g.
actinomycin D) and/or protein synthesis (e.g. cyclo-
heximide) inhibitors. Indeed, we have performed sim-
ilar experiments in cerebellar granule cells (8). Yet, we
were unable to obtain such data because both com-
pounds were highly cytotoxic in the first 12 h of treat-
ment (data not shown), whereas we require 16 h (Fig.
1B) to unmask effects on migration.
Fig. 5. Molecular Characterization of the Calcineurin/NFAT Pathway
A, Effect of the constructs used in the present study on luciferase activity in GN11 (black bars) or GT1-7 (hatched bars) cells.
Values are SEM of five to 20 replicates from one to four experiments. *, P 0.01 compared with respective controls using one-way
ANOVA, followed by Tukey’s test. B, Effect of dominant-negative constructs on GN11 migration. Cells negative for GFP are in
black, and their migration behavior did not differ from control cells. Cells were transiently transfected and, after 72 h, cell sorted
for GFP positivity. For the effect of constitutively active constructs or overexpression, see text. Values are SEM of 24–28 replicates
from three separate experiments. *, P  0.01 compared with respective controls using one-way ANOVA followed by Student’s
t test.
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In cerebellar granule cells, our group and others
have postulated, via indirect evidence (e.g. microarray
analysis), that calcineurin is activated upon completion
of migration (13, 14). This is apparently in contrast with
the findings reported here and demonstrates that cal-
cineurin does not positively regulate migration in all
neuronal or neuroendocrine cell types. On the other
hand, however, these opposing effects suggest that
calcineurin acts as a transcriptional switch in the de-
veloping nervous system and is able to facilitate tran-
sitions from one developmental stage to the next (e.g.
migration to maturation). Indeed, the nature of the
calcium transients required for calcineurin activation,
i.e. moderate in amplitude but prolonged in time,
would make this phosphatase perfect for such a tran-
sitional role. It is interesting to note that in our model,
it appears that the calcium elevation required for cal-
cineurin activation is provided by high unstimulated
basal levels of calcium and that GT1-7 cells display
lower basal levels. Our data therefore also suggest
that during development, calcium signaling is not nec-
essarily only a stimulated process but may also be
constitutively present under basal conditions. In this
context, it is interesting to note that among the genes
reported to be controlled by the CaN/NFAT pathway in
neurons are those involved in calcium homeostasis
(including pumps and exchangers) (8), maybe provid-
ing a feedback mechanism to this signal transduction
pathway. It is also striking that the CaN/NFAT pathway
itself undergoes changes upon migration, as demon-
strated by the disappearance of NFATc4 in GT1-7
cells (Fig. 3). Yet, these changes do not result in the
disappearance of the pathway altogether, because
mature cells are capable of activating it, presumably
upon stimulation, because transfection of a constitu-
tively active calcineurin leads to its activation (Fig. 5).
Neuronal migration will be controlled by numerous
signaling pathways in vivo (22), and some of these
pathways will be redundant and cell specific to allow
such a complex but fundamental behavior to occur.
Our data strongly suggest that in our model the Ca2/
calcineurin/NFAT pathway is among the primers that
determines the migratory potential of neurons. Yet, it
also highlights the switch nature of this phosphatase,
whose activation or inactivation guides cells to pro-
ceed from one genetic program to the next.
MATERIALS AND METHODS
Cell Cultures
GN11 and GT1-7 cells were originally provided by S. Radov-
ick (University of Chicago, Chicago, IL) and R. I. Weiner (San
Francisco, CA), respectively. The cells were grown in a mono-
layer at 37 C in a humidified CO2 incubator in DMEM con-
taining 1 mM sodium pyruvate, 2 mM glutamine, 100 g/ml
streptomycin, and 100 U/ml penicillin and supplemented with
10% FCS. The medium was replaced at 2-d intervals. Sub-
confluent cells were routinely harvested by trypsinization and
seeded in 57-cm2 dishes.
Chemicals, Plasmids, Antibodies, Transfection, and
PCR
FK506 and rapamycin were purchased from Calbiochem (La
Jolla, CA), and cyclosporin A and 2-APB were from Sigma-
Aldrich (St. Louis, MO).
GN11 cells were grown in culture plates in complete cul-
ture medium for 24 h and incubated for 3 h with the selected
expression vector in the presence of the Lipofectamine-Plus
Reagent (Invitrogen, Carlsbad, CA) according to the manu-
facturer’s instructions. The following plasmids were used:
pEGFP-N1 (Clontech, Palo Alto, CA), pLEGFP-C1 (Clontech),
CnA (23), NFAT (18), dominant-negative NFAT (amino ac-
ids 1–317 of the human NFATc4) in pAC-CMVpLpA (S)
kindly provided by the laboratory of Jeff Molkentin (Cincinnati
Children’s Hospital, Cincinnati, OH), CAIN in pRK5 (24),
pNFAT-TA-luc (Clontech), and pRL-TK (Promega, Madison,
WI).
For Western blotting, the following antibodies were used:
anti-NFATc4 (1:500, sc-13036; Santa Cruz Biotechnology,
Santa Cruz, CA) and antirabbit IgG (1:8000; Amersham Bio-
sciences, Arlington Heights, IL).
For immunocytochemistry, phalloidin-fluorescein isothio-
cyanate (Sigma-Aldrich) was used to visualize the actin cy-
toskeleton, whereas a polyclonal anti-GnRH antibody (Pro-
gen, Heidelberg, Germany) and a goat antirabbit Alexa Fluor
488 (Invitrogen) were used to visualize GnRH.
For evaluation of BDNF transcript level, a PCR approach
(94, 65, and 72 C for 30 cycles) was used with the following
primers: bdnf forward, CAATGAAAGAAGCAAACGTC;
bdnf reverse, GCTAATACTGTCACACACGCTC; gadph for-
ward, TGGCATTGTGGAAGGGCTCAT; and gadph reverse,
ATGCCAGTGAGCTTCCCGTTCAGC.
Microchemotaxis Assay
The assay was performed using a 48-well Boyden’s micro-
chemotaxis chamber according to the instructions (Neuro-
probe, Cabin John, MD). Briefly, the lower compartment of
the chamber was loaded with the chemoattractant (1 or 0.1%
FCS) or control medium; the cells, grown in complete me-
dium until subconfluent, were suspended (100,000; 20,000;
or 13,500 cells/50 l) in serum-free culture medium and
placed in the open-bottom wells of the upper compartment of
the Boyden’s chamber. Each pair of facing wells was sepa-
rated by a polyvinylpyrrolidone-free polycarbonate porous
membrane (8-m pores) precoated with gelatin (0.2 mg/ml in
PBS). The chamber was then kept for 3 h in the cell culture
incubator. At the end of the incubation period, the cells that
migrated through the pores and adhered to the underside of
the membrane were fixed and stained according to the Diff-
Quik kit (Biomap, Milano, Italy) and mounted onto glass
slides. For quantitative analysis, the membranes were ob-
served on a Nikon microscope using a 40 objective. Three
random fields of stained cells were counted for each well, and
the mean number of migrating cells was calculated. Numbers
in the text and figures are expressed as percentage of control
for clarity. In a typical experiment, an optical field contained
65  7 cells, which corresponded to 4815  518 cells in the
well. This experiment is indicative of most experiments,
where in 3 h approximately 20–25% of cells migrate to the
lower chamber.
Luciferase Assays
GN11 or GT1-7 cells were transfected with a luciferase re-
porter gene driven by NFAT (0.075 g/well) and a control
renilla reporter gene (0.075 g/well) in 96-well plates. After
3 h of transfection, cells were washed and treated with the
calcineurin inhibitors (FK506 100 nM; CyclosporinA 1 M) or
2-APB (100 M) for 48 h. Luciferase assays were performed
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with the dual luciferase reporter assay system (Promega) and
assessed using a multilabel counter (Victor3 V, Perkin Elmer).
Generation of NFAT-pLEGFP and pLEGFP Stable Cell
Lines
NFAT (18) was subcloned into pLEGFP-C1 and transfected
into Phoenix Retroviral Producer cells. The supernatant was
then used to infect GN11 cells. Selection was by G418 (500
g/ml). To speed up the procedure, cells were also sorted by
GFP fluorescence using stringent conditions to avoid cross-
contaminations using the FACSVantage SE DiVA cell sorter
(Becton Dickinson, Franklin Lakes, NJ). More than 99% of
cells were GFP fluorescent when experiments were per-
formed. In parallel, the same procedure was used to generate
a pLEGFP stable cell line, which was used as control.
Cell Sorting of Transient Expression
GN11 cells were cultured for 3 d after the cotransfection with
pEGFP-N1 and dnNFAT in pAC-CMVpLpA (S) or CAIN in
pRK5 in a 1:4 ratio. Cells were then resuspended (10 
106/ml) in PBS (Ca/Mg2-free) plus 5 mM EDTA, 25 mM
HEPES (pH 7.0), and 1% FCS and sorted into GFP and
GFP populations using stringent conditions to avoid cross-
contaminations using the MoFlo cell sorter (Dako Cytoma-
tion, Glostrup, Denmark).
Ca2 Measurements
To perform calcium imaging experiments, cells were loaded
for 30 min at 37 C with 1 M Fluo-4 AM (Invitrogen) and were
transferred in a perfusion chamber (Bioptechs, Butler, PA)
connected to a peristaltic pump and mounted on an inverted
microscope (Eclipse TE 300, Nikon, Japan). A microperfusion
system was employed to rapidly and locally perfuse a Tyrode
solution of the following composition (in mM): 154 NaCl, 4
KCl, 2 CaCl2, 1 MgCl2, 5 HEPES), 5.5 glucose, and NaOH to
pH 7.4 with added 10% BSA or FCS. Single-cell [Ca2]i
measurements were performed exciting Fluo-4 at 494 nm for
less than 200 msec, at a frequency of 0.2–1 Hz by means of
a monochromator (Polychrome IV, T.I.L.L.; Photonics GmbH,
Hamburg, Germany). Images were recorded with a cooled
CCD camera (SensiCam, PCO, Kehlheim, Germany) and
stored on a computer. Fluorescence was determined from
regions of interest covering single cell bodies. Dye excitation,
image acquisitions, and region-of-interest analysis protocols
were performed with Axon Imaging Workbench software
(Axon Instruments, Foster City, CA). Estimation of fluores-
cence intensity was performed as the pseudoratio F/F ac-
cording to the following formula: F/F  (F  Fbas)/(Fbas B),
where F is the measured fluorescence intensity of the Fluo-4
indicator, Fbas is the fluorescence intensity of the indicator in
the cell before stimulation, and B is the background signal
from the averaged areas adjacent to the cell.
Fura-2 was employed to estimate ratiometrically the intra-
cellular calcium concentrations. The indicator was added to
cultures for 30 min at 37 C at a final concentration of 0.5 M.
Fluorescence was excited every 0.3 sec alternatively at 340
and 380 nm for 100 msec, and emission was recorded at 510
nm. The intracellular calcium concentration was estimated
from the ratio image, as described by Grynkiewicz et al. (25).
All imaging experiments were performed at 27 C.
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